English | Español
Press release submission | Sep 23, 2018

ELI LILLY AND COMPANY: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults
Press release submission | Sep 16, 2018

GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Press release submission | Sep 16, 2018

ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia

Press release submission | Sep 5, 2018

LIVONGO HEALTH: Becomes First Comprehensive Diabetes Offering to Add Abbott’s FreeStyle® Libre Pro System to Platform
Press release submission | Sep 5, 2018

NUVASIVE INC: To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

Press release submission | Aug 29, 2018

CETERIX ORTHOPAEDICS: Announces FDA Clearance of New Suture Cartridge, Providing Increased Flexibility and Enhanced Options for Surgeons
Press release submission | Aug 29, 2018

ATRICURE, INC.: Announces Completion of Patient Enrollment in the CONVERGE IDE Clinical Trial
Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment